טוען...
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is heralded as the next big global epidemic. Hepatic de novo lipogenesis (DNL), the synthesis of new fatty acids from non-lipid sources, is thought to play a pivotal role in the development of NAFLD. While there is currently no NAFLD-specific therapeutic age...
שמור ב:
| הוצא לאור ב: | Lipids Health Dis |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5027077/ https://ncbi.nlm.nih.gov/pubmed/27640119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-016-0321-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|